Analysis of human immunodeficiency virus type 1 mRNA splicing patterns during disease progression in peripheral blood mononuclear cells from infected individuals

AIDS Research and Human Retroviruses

Volumn 12, Issue 15, 1996, Pages 1443-1456

  Saltarelli, M J ^a   Hadziyannis, E ^b   Hart, C E ^a   Harrison, J V ^b   Felber, B K ^b   Spira, T J ^b   Pavlakis, G N ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEROCONVERSION;

EID: 0029840257     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1443     Document Type: Article

References (72)

1. Lifson AR, Buchbinder SP, Sheppard HW, Mawle AC, Wilber JC, Stanley M, Hart CE, Hessol NA, and Holmberg SD: Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: Immunologic and virologic characteristics. J Infect Dis 1991; 163:959-965.
2. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332:201-208.
3. Willey RL, Theodore TS, and Martin MM: Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J Virol 1994;68:4409-4419.
4. Korber BTM, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, and Wolinsky SM: Genetic differences between bloodand brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68:7467-7481.
5. Parslow TC: Post-transcriptional regulation of human retroviral gene expression. In: Human Retroviruses (Cullen BR, ed.) IRL Press at Oxford University Press, New York, 1993, pp. 101-136.
6. Cullen BR: Regulation of gene expression in the human immunodeficiency virus type 1. Adv Virus Res 1991;40:1-17.
7. Pavlakis GN, Schwartz S, D'Agostino DM, and Felber BK: Structure, splicing, and regulation of expression of HIV-1: A model for the general organization of lentiviruses and other complex retroviruses. In: Annual Review of AIDS Research (Kennedy R, Wong-Staal F, and Koff WC, Eds.). Marcel Dekker, New York, 1991, pp. 41-63.
8. Neumann M, Kleinschmidt A, Felber BK, Froese B, Erfle V, Pavlakis GN, and Brack-Wemer R: Restriction of HIV-1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 1995;69:2159-2167.
9. Tornatore C, Nath A, Amemiya K, and Major EO: Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-l beta. J Virol 1991;65:6094-6100.
10. Trono D: HIV accessory proteins: Leading roles for the supporting cast. Cell 1995;82:189-192.
11. Subbramanian RA and Cohen EA: Molecular biology of the human immunodeficiency virus accessory proteins. J Virol 1994; 68:6831-6835.
12. Miller MD, Warmerdam MT, Gaston I, Greene WC, and Feinberg MB: The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994;179:101-113.
13. Miller MD, Warmerdam MT, Page KA, Feinberg MB, and Greene WC: Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progency particle infectivity independently of gp160 or viral entry. J Virol 1995;69:579-584.
14. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, and Richman DD: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994;179:115-123.
15. Kestler HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, and Desrosiers RC: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991;65:651-662.
16. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, and Desrosiers RC: Absence of intact nef sequences in long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-232.
17. Iversen AKN, Shpaer EG, Rodrigo AG, Hirsch MS, Walker BD, Sheppard HW, Merigan TC, and Mullins JI: Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol 1995;69:5743-5753.
18. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, and Mills J: Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-991.
19. Felber BK and Pavlakis GN: Molecular biology of HIV-1: Positive and negative regulatory elements important for viral expression. AIDS 1993;7 (Suppl.):S51-S62.
20. Schwartz S, Felber BK, Benko DM, Fenyö EM, and Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 1990; 64:2519-2529.
21. Schwartz S, Felber BK, and Pavlakis GN: Expression of human immunodeficiency virus type-1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 1991;183:677-686.
22. Schwartz S, Felber BK, Fenyö EM, and Pavlakis GN: Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol 1990;64:5448-5456.
23. Arya SK, Guo C, Josephs SF, and Wong-Staal F: Trans-activator gene of human T-lymphotrophic virus type III (HTLV-III). Science 1985;229:69-73.
24. Arya SK and Gallo RC: Three novel genes of human T-cell lymphotropic virus type III: Immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:2209-2213.
25. Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, and Capon DJ: Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (London) 1985; 313:450-458.
26. Benko DM, Schwartz S, Pavlakis GN, and Felber BK: A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol 1990;64:2505-2518.
27. Salfeld J, Gottlinger H, Sia R, Park R, Sodroski J, and Haseltine W: A tripartite HIV-1 Tat-Env-Rev fusion protein. EMBO J 1990;9:965-970.
28. Pavlakis GN, Schwartz S, Benko DM, Drysdale CM, Solomin L, Ciminale V, Robinson R, Harrison J, Campbell M, and Felber BK: Genome organization and regulation of HIV-1 expression. In: Genetic Structure and Regulation of HIV (Haseltine WA and Wong-Staal F, Eds.). Raven Press, New York, 1991, pp. 175-192.
29. Haseltine WA and Wong-Staal F: Genetic Structure and Regulation of HIV. Raven Press, New York, 1991, pp. 1-537.
30. Vaishnav YN, Vaishnav M, and Wong-Staal F: Identification and characterization of a nuclear factor that specifically binds to the Rev response element (RRE) of human immunodeficiency virus type 1 (HIV-1). New Biol 1991;3:142-150.
31. Rosen CA and Pavlakis GN: Tat and Rev: Positive regulators of HIV gene expression. AIDS 1990;4:499-509.
32. Rosen C: Regulatory proteins - Potential targets for therapeutic intervention. AIDS Res Hum Retroviruses 1992;8:175-181.
33. Pomerantz RJ, Trono D, Feinberg MB, and Baltimore D: Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell 1990;61:1271-1276.
34. Butera ST, Roberts BD, Lam L, Hodge T, and Folks TM: Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J Virol 1994;68:2726-2730.
35. Kim S, Bym R, Groopman J, and Baltimore D: Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J Virol 1989; 63:3708-3713.
36. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinical stage of disease. Nature (London) 1993;362:355-358.
37. Saksela K, Stevens C, Rubenstein P, and Baltimore D: Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the number of CD4+ lymphocytes. Proc Natl Acad Sci USA 1994; 91:1104-1108.
38. Seshamma T, Bagasra O, Trono D, Baltimore D, and Pomerantz RJ: Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:10663-10667.
39. Michael NL, Mo T, Merzouki A, O'Shaughnessy M, Oster C, Burke DS, Redfield RR, Birx DL, and Cassol SA: Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol 1995;69:1868-1877.
40. Furtado MR, Kingley LA, and Wolinsky SM: Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals. J Virol 1995;69:2092-2100.
41. Neumann M, Saltarelli M, Harrison J, Hadziyannis E, Felber BK, and Pavlakis GN: Splicing variability in HIV-1 revealed by quantitative RNA-PCR. AIDS Res Hum Retroviruses 1994;10:1527-1538.
42. Fishbein DB, Kaplan JE, Spira TJ, Miller B, Schonberger LB, Pinsky PF, Getchell JP, Kalyanaraman VS, and Braude JS: Unexplained lymphadenopathy in homosexual men: A longitudinal study. JAMA 1985;254:930-935.
43. Kaplan JE, Spira TJ, Fishbein DB, and Pinsky PF: Lymphadenopathy syndrome in homosexual men: Evidence of continuing risk of developing acquired immunodeficiency syndrome. JAMA 1987;257:335-337.
44. Kaplan JE, Spira TJ, Fishbein DB, Bozeman LH, Pinsky PF, and Schonberger LB: A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. JAMA 1988;260:2694-2697.
45. Kaplan JE, Spira TJ, Fishbein DB, and Lynn HS: Ten-year follow-up of HIV-infected homosexual men with lymphoadenopathy syndrome: Evidence for continuing risk of developing AIDS. J Acquir Immune Defic Syndr 1992;5:565-570.
46. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, and Shaw GM: High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991;324:954-960.
47. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, and Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
48. Graziosi C, Pantaleo G, Butini L, Demarest JF, Saag MS, Shaw GM, and Fauci AS: Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 1993;90:6405-6409.
49. Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110.
50. Myers G, Korber B, Berzofsky JA, Smith R, and Pavlakis GN: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1991.
51. Cohen OJ, Pantaleo G, Holodniy M, Schnittman S, Niu M, Graziosi C, Pavlakis GN, Lalezari J, Bartlett JA, Steigbigel RT, Cohn J, Novak R, McMahon D, and Fauci AS: Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc Natl Acad Sci USA 1995;92:6017-6021.
52. Ng SY, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, and Kedes L: Evolution of the functional B-actin gene and its multi-pseudogene family: Conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 1985;5:2720-2732.
53. D'Agostino DM, Felber BK, Harrison JE, and Pavlakis GN: The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag mRNA. Mol Cell Biol 1992;12:1375-1386.
54. Chretien S, Dubart A, Beaupain D, Raich N, Grandchamp B, Rosa J, Gossens M, and Romeo P-H: Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci USA 1988;85:5-10.
55. Grandchamp B, Verneuil HD, Beaumont C, Chretien S, Walter O, and Nordmann Y: Tissue-specific expression of porphobilinogen deaminase. Eur J Biochem 1987;162:105-110.
56. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
57. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EE, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
58. Purcell DFJ and Martin MA: Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993;67: 6365-6378.
59. Piatak M, Luk K-C, Williams B, and Lifson JD: Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques 1993;14:70-80.
60. Szilvay AM, Brokstad KA, Kopperud R, Haukenes G, and Kalland K-H: Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein is mediated by its activation domain and is blocked by transdominant negative mutants. J Virol 1995;69:3315-3323.
61. Richard N, Iacampo S, and Cochrane A: HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology 1994; 204:123-131.
62. D'Agostino DM, Ciminale V, Pavlakis GN, and Chieco-Bianchi L: Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: Involvement of continued rRNA synthesis in nuclear retention. AIDS Res Hum Retroviruses 1995;11: 1063-1072.
63. Meyer BE and Malim MH: The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev 1994; 8:1538-1547.
64. Kalland KH, Szilvay AM, Brokstad KA, Saetrevik W, and Haukenes G: The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol Cell Biol 1994;14:7436-7444.
65. Stauber R, Gaitanaris GA, and Pavlakis GN: Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: Transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology 1995;213:439-449.
66. Wolff B, Cohen G, Hauber J, Meshcheryakova D, and Rabeck C: Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Exp Cell Res 1995;217:31-41.
67. Malim MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR, and Nabel GJ: Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med 1992;176:1197-1201.
68. Woffendin C, Yang Z-Y, Udaykumar, Xu L, Yang N-S, Sheehy MJ, and Nabel GJ: Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc Natl Acad Sci USA 1994;91:11581-11585.
69. Duan L, Bagasra O, Laughlin MA, Oakes JW, and Pomerantz RJ: Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc Natl Acad Sci USA 1994;91:5075-5079.
70. Banner I, Zhou C, Yu X-J, Hao Q-L, Guatelli JC, and Kohn DB: Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J Virol 1993;67:3199-3207.
71. Bevec D, Dobrovnik M, Hauber J, and Böhnlein E: Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc Natl Acad Sci USA 1992;89: 9870-9874.
72. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995; 373:123-126.